Roivant Sciences Ltd. Common Shares (ROIV) is a publicly traded Healthcare sector company. As of May 20, 2026, ROIV trades at $32.08 with a market cap of $20.43B and a P/E ratio of -118.03. ROIV moved +13.86% today. Year to date, ROIV is +28.64%; over the trailing twelve months it is +160.24%. Its 52-week range spans $8.73 to $30.33. Analyst consensus is strong buy with an average price target of $35.31. Rallies surfaces ROIV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Roivant Sciences Ltd. Common Shares (ROIV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ROIV moved +13.86% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $32.08 |
| Market Cap | $20.43B |
| P/E Ratio | -118.03 |
| EPS | $-0.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.33 |
| 52-Week Low | $8.73 |
| Volume | 4.79M |
| Avg Volume | 0 |
| Revenue (TTM) | $29.05M |
| Net Income | $-356.73M |
| Gross Margin | 0.00% |
8 analysts cover ROIV: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $35.31.